Oncology Researchers Awarded DHT Summer Studentships
News Jul 01, 2013
The DHT scheme, now in its second year, enables undergraduates to extend their studies over the summer period by gaining practical lab experience, using non-animal approaches, that will further our understanding of devastating diseases.
Each award is worth up to £1,440 over a maximum 8 week period, with a separate budget of up to £500 available for consumables.
Professor Blair’s student, Jonathan Carr, who is studying for a BSc in Medical Biochemistry, will extend his studies by gaining practical laboratory experience to understand whether human adenoviruses can enter, spread and migrate through a multi-cellular tumour spheroid and whether this process can be monitored in real time using live cell imaging techniques.
Professor Hanemann’s student, Jade Lyons-Rimmer, who is studying for a BSc in Clinical Sciences, will aim to identify novel binding partners of KSR1 in human Schwann cells using a proteomics-based approach to further understand the roles of KSR1 in proliferation and apoptosis of Schwann cells. This project offers exciting replacement potential and this non-animal approach alone will prevent approximately 190 mice being used.
Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “Our Summer Studentship award is an opportunity to inspire the next generation of research students.
“We are really encouraged by the quality and quantity of the entries we have received this year. The winners of our awards clearly demonstrated how their animal-alternative research techniques had the potential to replace the use of many animals in conventional biomedical research.
"We are confident that the projects chosen will deliver not only valuable science but whet an appetite in these students to continue this work long after they graduate."
Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”News
Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.
Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.
Understanding the Process of Cell DivisionNews
Using multiple techniques such as structural modelling, X-ray scattering, X-ray crystallography and electron microscopy, scientists have found that the Spc110 protein provides a greater function in mitosis originally believed. This information could help understand the process in human cells and the abnormalities that occur in cancer.READ MORE